169 related articles for article (PubMed ID: 33554611)
1. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis.
Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo-Tcheugui JB; Martin DT; Joseph J; Singh JP
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009139. PubMed ID: 33554611
[TBL] [Abstract][Full Text] [Related]
2. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U
J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696
[TBL] [Abstract][Full Text] [Related]
3. End-of-life of implantable defibrillator: are we certain it should always be replaced?
Stazi F
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
[No Abstract] [Full Text] [Related]
4. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.
Packer M
Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e007430. PubMed ID: 31159583
[No Abstract] [Full Text] [Related]
5. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic risk stratification in patients with a primary prophylactic implantable cardioverter defibrillator: can future arrhythmias correlating with sudden cardiac death be predicted?
Zabel M; Friede T
Europace; 2024 Jun; 26(6):. PubMed ID: 38758091
[TBL] [Abstract][Full Text] [Related]
7. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
8. Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.
Boriani G; Botto G; Lunati M; Proclemer A; Schmidt B; Erdogan A; Rauhe W; Biffi M; Santi E; Becker D; Messier M; Santini M
BMC Cardiovasc Disord; 2012 Sep; 12():72. PubMed ID: 22966862
[TBL] [Abstract][Full Text] [Related]
9. Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.
Link MS; Sullivan RM; Olshansky B; Cannom D; Berul CI; Hauser RG; Heidbuchel H; Jordaens L; Krahn AD; Morgan J; Patton KK; Saarel EV; Wilkoff BL; Li F; Dziura J; Brandt C; Barth C; Lampert R
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009344. PubMed ID: 33724879
[No Abstract] [Full Text] [Related]
10. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
12. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
13. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients.
Zhou Y; Zhao S; Chen K; Hua W; Zhang S
BMC Cardiovasc Disord; 2019 May; 19(1):129. PubMed ID: 31146684
[TBL] [Abstract][Full Text] [Related]
15. The wearable cardioverter-defibrillator: current technology and evolving indications.
Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I
Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiology testing for risk stratification of patients with ischaemic cardiomyopathy: a call for action.
Katritsis DG; Zografos T; Hindricks G
Europace; 2018 Sep; 20(FI2):f148-f152. PubMed ID: 29236981
[TBL] [Abstract][Full Text] [Related]
17. Wearable cardioverter-defibrillators: A review of evidence and indications.
Cheung CC; Olgin JE; Lee BK
Trends Cardiovasc Med; 2021 Apr; 31(3):196-201. PubMed ID: 32205034
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardiac electronic device therapy for patients with a systemic right ventricle.
Barracano R; Brida M; Guarguagli S; Palmieri R; Diller GP; Gatzoulis MA; Wong T
Heart; 2020 Jul; 106(14):1052-1058. PubMed ID: 32269130
[TBL] [Abstract][Full Text] [Related]
19. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
[TBL] [Abstract][Full Text] [Related]
20. Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study.
Gunten SV; Theuns DA; Kühne M; Reichlin T; Sticherling C; Schaer B
Cardiol J; 2019; 26(6):711-716. PubMed ID: 30484267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
